13 January 2020 - Suerie Moon and colleagues consider what makes a fair price for both buyers and sellers.

High and rising prices of medicines have attracted public concern from the poorest to richest countries. For example, of 1,500 patient groups surveyed in 78 countries, only 9% believed that pharmaceutical companies were “excellent or good” at having “fair pricing policies”. This figure has hovered between 11% and 15% since the survey began in 2011.

Politicians, experts, physicians, patients, and pharmaceutical executives have hotly debated whether medicines prices are fair, but without agreeing on what “fairness” means.

Read BMJ article